Ad
related to: 4 Antibody Test- Search Tests by Condition
Select a condition or disease state
to find tests relevant for you.
- Direct Labs at $12.95
30 Popular Lab Tests - Only $12.95
No Dr. Required | Quick Results
- Search Tests by Condition
Search results
FDA’s Final LDT Rule Is Here, and the Changes Show the Agency Is Serious and Actually Listening to...
The National Law Review· 6 days agoThe Food and Drug Administration (FDA) published its final rule on laboratory developed tests (LDTs)...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 days agoPRESS RELEASE - 06/05/2024, 07:00 CEST Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region Biocartis (Mechelen, Belgium) announced an expansion of its collaboration
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
Rome Sentinel· 3 days agoCash, cash equivalents, marketable securities and restricted cash totaled approximately $287.6 million on March 31, 2024, which excludes the net proceeds of approximately $247.8 million from Biohaven's public offering completed
Bird flu is bad for poultry and dairy cows. It’s not a dire threat for most of us - yet
The State· 5 days agoHeadlines are flying after the Department of Agriculture confirmed that the H5N1 bird flu virus has ...
There's a new highly transmissible COVID-19 variant. Could FLiRT lead to a summer uptick?
Los Angeles Times· 2 days agoTwo new COVID-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter’s...
Covid subvariants leading infections | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 10 hours agoTwo new covid-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter's...
The End of an Era? FDA Finalizes LDT Rule But Grandfathers Many Existing LDTs | JD Supra
JD Supra· 6 days agoOn May 6, 2024, the Food and Drug Administration (FDA) published its final rule for laboratory developed tests (LDTs). The final rule cemented the agency’s forecasted decision to increase the ...
C3 Glomerulopathy Diagnosis
Medscape· 4 days agoC3 glomerulopathy (C3G) is a group of kidney diseases caused by dysregulation of the alternative complement pathway, resulting in abnormal deposition of...
Sera Prognostics, Inc. (NASDAQ:SERA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoSera Prognostics, Inc. (NASDAQ:SERA) Q1 2024 Earnings Call Transcript May 8, 2024 Sera Prognostics,...
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Morningstar· 2 days agoTORONTO, ON / ACCESSWIRE / May 10, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
